U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry MIXED
Molecular Formula C33H53NO3
Molecular Weight 511.7788
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NABOCTATE

SMILES

CCCCCCCC(C)C1=CC2=C(C(OC(=O)CCCN(CC)CC)=C1)C3=C(CCC(C)C3)C(C)(C)O2

InChI

InChIKey=UDQAWRWPAGUCRX-UHFFFAOYSA-N
InChI=1S/C33H53NO3/c1-8-11-12-13-14-16-25(5)26-22-29(36-31(35)17-15-20-34(9-2)10-3)32-27-21-24(4)18-19-28(27)33(6,7)37-30(32)23-26/h22-25H,8-21H2,1-7H3

HIDE SMILES / InChI

Molecular Formula C33H53NO3
Molecular Weight 511.7788
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Naboctate (SP-325) is a synthetic cannabinoid receptor agonist, which has antiemetic, sedative, anxiolytic and anti-glaucoma properties. In a normotensive rabbit model, topically applied naboctate in aqueous solution induced dose-related decreases in intraocular pressure.

Approval Year

Sample Use Guides

In Vivo Use Guide
aq. soln. 0.2, 0.5, and 1​%
Route of Administration: Topical
Substance Class Chemical
Record UNII
N6YFU80HRG
Record Status Validated (UNII)
Record Version